openPR Logo
Press release

Cancer Biomarker Testing Market Growth, Size, Investment Forecast & Key Players Analysis To 2025 - F. Hoffmann-La Roche Ltd, Illumina, Inc., Thermo Fisher Scientific Inc

06-30-2025 09:23 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Cancer Biomarker Testing Market

Cancer Biomarker Testing Market

The Global Cancer Biomarker Testing Market reached US$24.86 billion in 2024 and is expected to reach US$67.74 billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033.

Cancer Biomarker Testing Market Industry Outlook - Strategic Insights for 2025

Cancer Biomarker Testing Market is witnessing transformative growth in 2025, driven by evolving consumer demand, technology disruption, and sustainability trends. The newly released market research report by DataM Intelligence offers deep insights into segmentation, competitive landscape, and growth forecasts, helping marketers and decision-makers formulate high-impact strategies.

Get exclusive insights with our detailed sample report (Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/cancer-biomarker-testing-market?kb

Cancer biomarker testing refers to the process of identifying specific biological molecules, genes, or proteins in blood, tissue, or bodily fluids that indicate the presence, type, or progression of cancer. These biomarkers are crucial for early detection, personalized treatment planning, monitoring therapeutic response, and predicting cancer recurrence.

Leading Market players in the Cancer Biomarker Testing Market

The prominent players in Cancer Biomarker Testing market research report are:

F. Hoffmann-La Roche Ltd, Illumina, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Guardant Health, Agilent Technologies, Inc., Quanterix, Exact Sciences Corporation, QIAGEN and Takara Bio Inc., among others.

These companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Industry Development

In August 2024, Illumina, Inc. secured FDA approval for its TruSight Oncology (TSO) Comprehensive test, an in vitro diagnostic (IVD), along with its first two companion diagnostic (CDx) indications.

In April 2024, Takara Bio USA, Inc. introduced the Shasta Single-Cell System an automated, high-throughput NGS platform featuring robust chemistries and user-friendly bioinformatics tools, designed to support novel biomarker discovery in oncology research.

Market Segments

By Test Type: Genetic Biomarker Testing, Protein Biomarker Testing, Circulating Tumor DNA (ctDNA) Testing, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Others

By Product Type: Instruments (PCR Machines, NGS Platforms, Mass Spectrometers, ctDNA Detection Devices, Others), Kits & Reagents

By Cancer Type: Lung Cancer, Prostate Cancer, Breast Cancer, Leukemia, Others

By Application: Drug Discovery and Development, Disease Screening, Treatment Planning, Others

Research Methodology:

The global Cancer Biomarker Testing Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Speak to Our Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/cancer-biomarker-testing-market?kb

Regions Covered:

The global Cancer Biomarker Testing Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Most Frequently Asked Questions in the Cancer Biomarker Testing Market Research Industry:

➠ Who leads the Cancer Biomarker Testing industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Cancer Biomarker Testing market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Cancer Biomarker Testing market growth?
➠ What are the dominant sales and distribution strategies in the Cancer Biomarker Testing industry?

Purchase Your Subscription to Power Your Strategy with Precision: https://www.datamintelligence.com/reports-subscription?kb

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Biomarker Testing Market Growth, Size, Investment Forecast & Key Players Analysis To 2025 - F. Hoffmann-La Roche Ltd, Illumina, Inc., Thermo Fisher Scientific Inc here

News-ID: 4086414 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

United States Induction Motor Market 2031 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Induction Motor Market 2031 | Growth Drivers, Trends & Market Fore …
Induction Motor Market size was worth US$ 20.36 billion in 2023 and is estimated to reach US$ 33.66 billion by 2031, growing at a CAGR of 6.49% during the forecast period (2024-2031). Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/induction-motor-market?kb List of Top Key Player: ABB Ltd., Ametek, Emerson Electric, Siemens AG, Brook Crompton, Danaher Corporation, Johnson Electric Holdings, Regal Beloit, WEG Electric Corp.
Digital Therapeutics Market Set for Explosive Growth to USD 39.52 Billion by 2033, Led by North America's 42% Market Share | DataM Intelligence
Digital Therapeutics Market Set for Explosive Growth to USD 39.52 Billion by 203 …
The Global Digital Therapeutics Market size reached USD 6.84 billion in 2024 and is expected to reach USD 39.52 billion by 2033, growing at a CAGR of 21.6% during the forecast period 2025-2033. Market growth is driven by the rising prevalence of chronic diseases like diabetes and mental health disorders, increasing smartphone penetration, and growing patient demand for personalized, app-based interventions. Advancements in AI and machine learning for behavior change, expanding
United States Contrast Media Injectors Market: Real-Time Market Trends & Competitive Landscape
United States Contrast Media Injectors Market: Real-Time Market Trends & Competi …
DataM Intelligence unveils its latest report on the "Contrast Media Injectors Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies
United States Real Time Location System (RTLS) Market Analysis 2026: Growth Drivers, Key Developments, Market Growth, Future Insights, Investment
United States Real Time Location System (RTLS) Market Analysis 2026: Growth Driv …
Real Time Location System (RTLS) Market is expected to grow at a CAGR of 18% during the forecasting period (2022-2029). Request a Premium Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://www.datamintelligence.com/download-sample/real-time-location-system-market?kb United States: Recent Industry Developments ✅ December 2025: Major healthcare systems expanded RTLS deployments to enhance patient tracking, asset utilization, and workflow efficiency. ✅ November 2025: Leading tech providers integrated AI‐driven analytics into RTLS platforms to deliver predictive

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For